MAIA: Louie Ngar Yee discloses securities transactions

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Louie Ngar Yee

Reporting filer

Louie Ngar Yee reported Grant or award in MAIA Biotechnology, Inc.: 39634 units of Stock Options (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 2, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Options (derivative)	Louie Ngar Yee	2026-09-30	A	Grant or award	39634	0	39,634	2 days	Filed terms security Title: Stock Options conversion Or Exercise Price: 1.18 transaction Date: 2026-09-30 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 39634 transaction Price Per Share: 0 transaction Acquired Disposed Code: A exercise Date: 2026-09-30 id: F1 expiration Date: 2036-09-30 underlying Security Title: Common Stock underlying Security Shares: 39634 shares Owned Following Transaction: 39634 direct Or Indirect Ownership: D

Stock Options (derivative)

Owner: Louie Ngar Yee
Date: 2026-09-30
Code: A
Action: Grant or award
Quantity: 39634
Price: 0
Following holdings: 39,634
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Options
conversion Or Exercise Price: 1.18
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 39634
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
exercise Date: 2026-09-30
id: F1
expiration Date: 2036-09-30
underlying Security Title: Common Stock
underlying Security Shares: 39634
shares Owned Following Transaction: 39634
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Louie Ngar Yee: Director.
F1: The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Stock Options (derivative)

Louie Ngar Yee

2026-09-30

Grant or award

39634

39,634

2 days

Filed terms

security Title: Stock Options
conversion Or Exercise Price: 1.18
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 39634
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
exercise Date: 2026-09-30
id: F1
expiration Date: 2036-09-30
underlying Security Title: Common Stock
underlying Security Shares: 39634
shares Owned Following Transaction: 39634
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Louie Ngar Yee: Director.

F1: The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.